DCVC Bio

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-10-08

ROUNDS

as lead investor

LEAD SHARE · USD

$33.7M

across 1 round · 1 co-led, split evenly

LATEST ROUND

Series A · $101M · 2025-10-08

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

DCVC Bio: led 1 round · Fireround

Company	Round	Amount	Announced	Role
Nilo Nilo Therapeutics develops medicines that target neural circuits to restore immune balance in autoimmune and inflammatory disease.	Series A Verified against 3 sources	$101M	2025-10-08	[ LEAD ]